Skip to main content
. 2022 Sep 16;23(18):10823. doi: 10.3390/ijms231810823

Figure 2.

Figure 2

Roles of miR-149-5p in non-small cell lung cancer (NSCLC), nasopharyngeal carcinoma (NPC), breast cancer (BC), triple-negative breast cancer (TNBC), cervical cancer, endometrial carcinoma (EC), and bladder cancer.